WILLIAM BACON: Open Payments
NPI 1730181942 · SANTA FE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 12 payments from 8 companies in 2025. Trend: 2023 $1,226 · 2024 $1,417 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $134 |
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Verona Pharma, Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Lilly USA, LLC | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: WATCHMAN Access System, Ohtuvayre, BREZTRI, PLUVICTO, MOUNJARO, ZENPEP, FARXIGA, XIFAXAN.
Industry payments across NM — which companies pay providers there.
